Abstract
Objective
To assess the epidemiological and clinical characteristics of pediatric inpatients with COVID-19, early in the pandemic.
Methods
Clinical and laboratory profile and outcomes were studied for children (aged 1 month — 18 years) presenting between 1 April, 2020 and 20 May, 2020 with positive nasopharyngeal swab for SARS-CoV-2 by RT-PCR.
Results
50 children (56% male) with median (IQR) age of 6 (2–12) years were included. Majority (56%) were from families belonging to Kuppuswamy upper lower socioeconomic class. 45 (90%) had positive household contact, and 33 (66%) had overcrowding at home. 29 (58%) children were asymptomatic while 20 (40%) had mild symptoms. Fever, cough, and sore throat were the most common symptoms. High C-reactive protein levels were seen in 15 (30%) children. There was no mortality.
Conclusion
The disease burden appears high in lower socio-economic group with majority having a positive household contact. Milder disease pattern in the pediatric age group is reiterated.
Keywords: Management, RT-PCR, SARS-CoV-2, Symptoms, Outcome
Contributors
VSR,BS,AP,MC: management of the patients; VSR,BS: collected the data, reviewed the literature and drafted the first version of the manuscript; BS,JSO,NM,SL: conceptualized the study, reviewed the literature, revised the manuscript and critically reviewed the manuscript. All authors contributed to manuscript preparation and approved the final version of the manuscript.
Funding
None
Ethical approval
Institutional Ethics Committee of Bharati Vidyapeeth Medical College and Hospital; No. BVUDMC/IEC/1B, dated 10 April, 2020.
Footnotes
Competing interests
None stated.
References
- 1.Riou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro Surveill. 2020;25:2000058 [DOI] [PMC free article] [PubMed]
- 2.Guidelines On Clinical Management Of COVID-19. Government of India Ministry of Health & Family Welfare Directorate General of Health Services (EMR Division), pp.3–5. Available at: https://www.mohfw.gov.in/pdf/GuidelinesonClinicalManagementofCOVID1912020.pdf. Accessed July 27, 2020.
- 3.Toussie D, Voutsinas N, Finkelstein M, Cedillo M, Manna S, Maron S, et al. Clinical and chest radiography features determine patient outcomes in young and middle age adults with COVID-19. Radiol. 2020;201754. [DOI] [PMC free article] [PubMed]
- 4.Global Surveillance for human infection with novel coronavirus(2019-nCoV). Available from: https://www.who.int/publications-detail/global-surveillance-for-human-infection-with-novel-coronavirus-(2019-ncov). Accessed June 20, 2020
- 5.Park K. Environment and Health. In: Park K, editor. Park’s Textbook of Preventive and Social Medicine. 23rd ed. Jabalpur: Bhanot Publishers; 2015. p. 758. [Google Scholar]
- 6.Coronavirus Disease 2019 (COVID-19). Centers for Disease Control and Prevention. 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/racial-ethnic-minorities.html. Accessed June 20, 2020.
- 7.Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: An observational cohort study. Lancet Infect Dis. 2020;20:689–96. doi: 10.1016/S1473-3099(20)30198-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Meena J, Yadav J, Saini L, Yadav A, Kumar J. Clinical features and outcome of SARS-CoV-2 infection in children: A systematic review and meta-analysis. Indian Pediatr. 2020 Jun 24. S097475591600203 [Epub ahead of print]. [DOI] [PMC free article] [PubMed]
- 9.COVID-19: Data Summary — NYC Health. Available from: https://www1.nyc.gov/site/doh/covid/covid-19-data.page. Accessed June 20, 2020
- 10.Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–80.e8. doi: 10.1016/j.cell.2020.02.052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Li T, Zhang Y, Gong C, Wang J, Liu B, Shi L, et al. Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China. Eur J Clin Nutr. 2020;74:871–9. doi: 10.1038/s41430-020-0642-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lagunas-Rangel FA. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. J Med Virol. 2020;10.1002/jmv.25819 [published online ahead of print, 2020 Apr 3]. [DOI] [PMC free article] [PubMed]
- 13.Wang L. C-reactive protein levels in the early stage of COVID-19. Med Mal Infect. 2020;50:332–4. doi: 10.1016/j.medmal.2020.03.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Lauri A, Mariani PO. Potentials and limitations of molecular diagnostic methods in food safety. Genes Nutr. 2008;4:1–12. doi: 10.1007/s12263-008-0106-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Bullard J, Dust K, Funk D, Strong JE, Alexander D, Garnett L, et al. Predicting infectious SARS-CoV-2 from diagnostic samples. Clin Infect Dis. 2020;ciaa638 [published online ahead of print, 2020 May 22]. [DOI] [PMC free article] [PubMed]